CEO of GSK plays down its role in FDA effort to approve therapy for autism-related condition The drugmaker has no commercial or scientific interest in the matter, Walmsley says

https://www.statnews.com/2025/10/15/gsk-leucovorin-autism-treatment-walmsley/